Alto Neuroscience (ANRO) News Today $2.92 +0.27 (+10.26%) Closing price 03:59 PM EasternExtended Trading$2.83 -0.09 (-3.15%) As of 04:31 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrendsBuy This Stock ANRO Latest News All Sources Trusted Sources MarketBeat Benzinga Bloomberg GlobeNewswire GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent July 2025 June 2025 May 2025 April 2025 March 2025 February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 Time Period ANRO - Alto Neuroscience Inc Financials - MorningstarJuly 2, 2025 | morningstar.comMAlto Neuroscience Highlights Peer-Reviewed Publication of PAX-D Study in The Lancet Psychiatry Demonstrating Robust Clinical Effects of Pramipexole for Patients with Treatment ...June 30, 2025 | uk.finance.yahoo.comAlto Neuroscience Highlights Peer-Reviewed Publication of PAX-D Study in The Lancet Psychiatry Demonstrating Robust Clinical Effects of Pramipexole for Patients with Treatment-Resistant DepressionJune 30, 2025 | businesswire.comAlto Neuroscience, Inc. (NYSE:ANRO) Given Average Rating of "Moderate Buy" by BrokeragesJune 29, 2025 | marketbeat.comHC Wainwright Reiterates "Buy" Rating for Alto Neuroscience (NYSE:ANRO)June 26, 2025 | marketbeat.comPromising Phase 2 Results for ALTO-203 in Treating Anhedonia-MDD Justify Buy RatingJune 26, 2025 | tipranks.comAlto Neuroscience Identifies Biomarker and Reports Positive Pharmacodynamic Results from Exploratory Phase 2 Proof-of-Concept Trial of ALTO-203June 26, 2025 | businesswire.comAlto Neuroscience Announces Acquisition of Novel Dopamine Agonist Combination Product Candidate, Adding Late-Stage Readout in Treatment Resistant Depression Within Current Cash ...June 4, 2025 | morningstar.comMH.C. Wainwright Affirms Buy Rating on Alto Neuroscience (ANRO), Sets $10 PTJune 4, 2025 | msn.comAlto Neuroscience, Inc. (NYSE:ANRO) Receives Average Recommendation of "Moderate Buy" from AnalystsJune 4, 2025 | marketbeat.comStrategic Acquisition and Promising Clinical Developments Drive Buy Rating for Alto Neuroscience, Inc.June 3, 2025 | tipranks.comAlto Neuroscience Announces Acquisition of Novel Dopamine Agonist Combination Product Candidate, Adding Late-Stage Readout in Treatment Resistant Depression Within Current Cash RunwayJune 3, 2025 | businesswire.comANRO Alto Neuroscience, Inc.June 1, 2025 | seekingalpha.comAlto Neuroscience Presents Data at the 2025 American Society of Clinical Psychopharmacology Annual Meeting Reinforcing Safety and Tolerability Profile for ALTO-300 in Major Depressive DisorderMay 29, 2025 | businesswire.comAlto Neuroscience to Participate in Upcoming Investor ConferencesMay 28, 2025 | businesswire.comWoodline Partners LP Has $2.63 Million Holdings in Alto Neuroscience, Inc. (NYSE:ANRO)May 27, 2025 | marketbeat.comNorthern Trust Corp Acquires 390,190 Shares of Alto Neuroscience, Inc. (NYSE:ANRO)May 26, 2025 | marketbeat.comHC Wainwright Expects Reduced Earnings for Alto NeuroscienceMay 24, 2025 | marketbeat.comAWM Investment Company Inc. Acquires 128,100 Shares of Alto Neuroscience, Inc. (NYSE:ANRO)May 23, 2025 | marketbeat.comPoint72 Asset Management L.P. Has $7.16 Million Position in Alto Neuroscience, Inc. (NYSE:ANRO)May 22, 2025 | marketbeat.comVestal Point Capital LP Raises Stock Holdings in Alto Neuroscience, Inc. (NYSE:ANRO)May 21, 2025 | marketbeat.comQ2 Earnings Forecast for Alto Neuroscience Issued By WedbushMay 20, 2025 | marketbeat.comQ2 EPS Forecast for Alto Neuroscience Reduced by AnalystMay 20, 2025 | marketbeat.comAlto Neuroscience Advances Precision Psychiatry PipelineMay 15, 2025 | tipranks.comAlto Neuroscience Reports First Quarter 2025 Financial Results and Recent Business HighlightsMay 15, 2025 | finance.yahoo.comOrbimed Advisors LLC Acquires New Position in Alto Neuroscience, Inc. (NYSE:ANRO)May 15, 2025 | marketbeat.comIntegral Health Asset Management LLC Buys New Shares in Alto Neuroscience, Inc. (NYSE:ANRO)May 14, 2025 | marketbeat.comStifel Financial Corp Takes $544,000 Position in Alto Neuroscience, Inc. (NYSE:ANRO)May 13, 2025 | marketbeat.comAlto Neuroscience, Inc. (NYSE:ANRO) Receives Consensus Recommendation of "Moderate Buy" from AnalystsMay 12, 2025 | marketbeat.comAlto Neuroscience Stock Short Interest Report | NYSE:ANRO | BenzingaMay 10, 2025 | benzinga.comAlto Neuroscience (ANRO) Expected to Announce Quarterly Earnings on TuesdayMay 8, 2025 | marketbeat.comCantor Fitzgerald L. P. Buys Shares of 375,000 Alto Neuroscience, Inc. (NYSE:ANRO)May 7, 2025 | marketbeat.comAlkeon Capital Management LLC Has $2.02 Million Stock Holdings in Alto Neuroscience, Inc. (NYSE:ANRO)May 5, 2025 | marketbeat.comAlmitas Capital LLC Takes Position in Alto Neuroscience, Inc. (NYSE:ANRO)May 4, 2025 | marketbeat.comAlto Neuroscience Presents New Data at the Society of Biological Psychiatry Annual Meeting Underscoring Precision Psychiatry ApproachApril 28, 2025 | businesswire.comMarshall Wace LLP Makes New $3.54 Million Investment in Alto Neuroscience, Inc. (NYSE:ANRO)April 28, 2025 | marketbeat.comAlto Neuroscience to Participate in the JonesResearch Virtual CNS DayApril 22, 2025 | finance.yahoo.comAlto Neuroscience, Inc. (NYSE:ANRO) Receives Consensus Recommendation of "Moderate Buy" from BrokeragesApril 17, 2025 | marketbeat.comWhat is HC Wainwright's Forecast for ANRO Q1 Earnings?April 12, 2025 | marketbeat.comAlto Neuroscience (NYSE:ANRO) Now Covered by HC WainwrightApril 9, 2025 | marketbeat.comAlto Neuroscience initiated with a Buy at H.C. WainwrightApril 8, 2025 | markets.businessinsider.comHC Wainwright & Co. Initiates Coverage of Alto Neuroscience (ANRO) with Buy RecommendationApril 8, 2025 | msn.comJonesTrading Sticks to Its Buy Rating for Alto Neuroscience, Inc. (ANRO)March 25, 2025 | markets.businessinsider.comBuy Rating Reaffirmed for Alto Neuroscience, Inc. Amid Promising Pipeline and Upcoming Data ReadoutsMarch 24, 2025 | tipranks.comWhat is Wedbush's Estimate for ANRO FY2029 Earnings?March 24, 2025 | marketbeat.comWhat is William Blair's Forecast for ANRO Q1 Earnings?March 24, 2025 | marketbeat.comAnalysts Offer Insights on NA Companies: Reddit Inc Class A (RDDT) and Alto Neuroscience, Inc. (ANRO)March 22, 2025 | markets.businessinsider.comALTO NEUROSCIENCE Earnings Results: $ANRO Reports Quarterly EarningsMarch 22, 2025 | nasdaq.comAlto Neuroscience, Inc. (ANRO) Gets a Hold from WedbushMarch 22, 2025 | markets.businessinsider.comAlto Neuroscience, Inc. (NYSE:ANRO) Given Average Rating of "Moderate Buy" by AnalystsMarch 22, 2025 | marketbeat.com Get Alto Neuroscience News Delivered to You Automatically Sign up to receive the latest news and ratings for ANRO and its competitors with MarketBeat's FREE daily newsletter. Email Address ANRO Media Mentions By Week ANRO Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. ANRO News Sentiment▼0.000.96▲Average Medical News Sentiment ANRO News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. ANRO Articles This Week▼02▲ANRO Articles Average Week Get Alto Neuroscience News Delivered to You Automatically Sign up to receive the latest news and ratings for ANRO and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies Sagimet Biosciences News Today Prima BioMed News Today Cardiff Oncology News Today Adherex Technologies News Today Inhibrx Biosciences News Today Canopy Growth News Today Esperion Therapeutics News Today biote News Today Nanobiotix News Today ProQR Therapeutics News Today Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NYSE:ANRO) was last updated on 7/17/2025 by MarketBeat.com Staff From Our PartnersINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredMarket Panic: Trump Just Dropped a Bomb on Your Stockstock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tarif...American Alternative | SponsoredThis Signal Only Flashes Once Every 4 Years – And It Just TriggeredThis same signal has appeared twice before in the past 8 years — both times, it kicked off major moves in cryp...Crypto Swap Profits | SponsoredI was wrong about TrumpI made a mistake. A mistake I feel very foolish about. After speaking with Donald Trump and some of his ...Porter & Company | SponsoredPresidential Bombshell: $150T Resource to Be Released as soon as this Summer?Something extraordinary is happening in Washington. For the first time in over a century, a sitting Preside...Paradigm Press | SponsoredYour blueprint for crypto wealthMark August 12th on your calendar. 27 of crypto's most successful minds are about to reveal everything…Crypto 101 Media | Sponsored[No Brainer Gold Play]: “Show me a better investment.”A Historic Gold Announcement Is About to Rock Wall Street? For months, sharp-eyed analysts have watched the...Golden Portfolio | SponsoredThe DOJ Just Paved the Way for Account SeizuresWashington is running out of money…And guess where they'll look next? When governments go broke, they take ...Priority Gold | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Alto Neuroscience, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Alto Neuroscience With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free ANRO Stock Alerts